AU660290B2 - Multiple drug delivery system - Google Patents

Multiple drug delivery system

Info

Publication number
AU660290B2
AU660290B2 AU86103/91A AU8610391A AU660290B2 AU 660290 B2 AU660290 B2 AU 660290B2 AU 86103/91 A AU86103/91 A AU 86103/91A AU 8610391 A AU8610391 A AU 8610391A AU 660290 B2 AU660290 B2 AU 660290B2
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
multiple drug
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU86103/91A
Other versions
AU8610391A (en
Inventor
Robert J Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endocon Inc
Original Assignee
Endocon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endocon Inc filed Critical Endocon Inc
Publication of AU8610391A publication Critical patent/AU8610391A/en
Application granted granted Critical
Publication of AU660290B2 publication Critical patent/AU660290B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
AU86103/91A 1990-08-09 1991-08-06 Multiple drug delivery system Ceased AU660290B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56527390A 1990-08-09 1990-08-09
US565273 1990-08-09
PCT/US1991/005574 WO1992002211A1 (en) 1990-08-09 1991-08-06 Multiple drug delivery system

Publications (2)

Publication Number Publication Date
AU8610391A AU8610391A (en) 1992-03-02
AU660290B2 true AU660290B2 (en) 1995-06-22

Family

ID=24257894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86103/91A Ceased AU660290B2 (en) 1990-08-09 1991-08-06 Multiple drug delivery system

Country Status (6)

Country Link
EP (1) EP0542915A1 (en)
JP (1) JPH11508224A (en)
AU (1) AU660290B2 (en)
CA (1) CA2088982A1 (en)
HU (1) HUT69680A (en)
WO (1) WO1992002211A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1979392A (en) * 1991-05-14 1992-12-30 Endocon, Inc. Engineering the local inflammatory response as a means of controlled release drug delivery
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
ES2087337T3 (en) * 1991-06-24 1996-07-16 American Cyanamid Co IMPLANT COMPOSITIONS CONTAINING A BIOLOGICALLY ACTIVE PROTEIN, PEPTIDE OR POLYPEPTIDE.
ES2150427T3 (en) * 1992-06-02 2000-12-01 Bard Inc C R PROCEDURE AND DEVICE OF IMPLANT FOR THE SUPPLY OF LONG-TERM DRUGS.
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
AU710749B2 (en) * 1994-10-25 1999-09-30 Daratech Pty Ltd Controlled release container with core and outer shell
DE19608423A1 (en) * 1996-03-05 1997-09-11 Merck Patent Gmbh Phased drug delivery implants
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
EP1458352A1 (en) * 2001-12-18 2004-09-22 Novo Nordisk A/S Solid dose micro implant
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
TWI357815B (en) * 2003-06-27 2012-02-11 Euro Celtique Sa Multiparticulates
EP3030286B1 (en) 2013-08-05 2019-10-09 Cam Med LLC Conformable patch pump
WO2018064544A1 (en) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible contraceptive implant and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1311088A (en) * 1987-03-16 1988-09-15 Monsanto Technology Llc Somatotropin prolonged release

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
WO1990010437A1 (en) * 1989-03-09 1990-09-20 Endocon, Inc. Partially fused peptide pellet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1311088A (en) * 1987-03-16 1988-09-15 Monsanto Technology Llc Somatotropin prolonged release

Also Published As

Publication number Publication date
HUT69680A (en) 1995-09-28
EP0542915A1 (en) 1993-05-26
AU8610391A (en) 1992-03-02
JPH11508224A (en) 1999-07-21
HU9300313D0 (en) 1993-11-29
CA2088982A1 (en) 1992-02-10
WO1992002211A1 (en) 1992-02-20

Similar Documents

Publication Publication Date Title
AU4989993A (en) Drug delivery system
AU664807B2 (en) Drug delivery system
AU3050892A (en) Delivery system
AU6534894A (en) Drug administration system
AU4505496A (en) Sustained-release drug delivery system
AU6820687A (en) Drug delivery system
EP0662851A4 (en) Drug delivery system.
AU8263987A (en) Pharmaceutical Delivery Systems
AU8397091A (en) Medication management system
AU1966892A (en) Cosmetic delivery system
AU8935591A (en) Drug delivery system and method
AU3204995A (en) Closed drug delivery system
AU2399092A (en) Aerosol delivery system
AU8253791A (en) Delivery catheter
AU7160991A (en) Multi-unit pulsatile delivery system
AU4227793A (en) Drug infuser
AU1967792A (en) Cosmetic delivery system
AU587925B2 (en) Hanky delivery system
AU660290B2 (en) Multiple drug delivery system
AU5260990A (en) Roboting drug dispensing system
GB9325330D0 (en) Fluorocyclodextrin drug delivery system
GB9404293D0 (en) Drug delivery system
AU6564590A (en) Medication dispenser
EP0636363A3 (en) Drug delivery system.
AU6510094A (en) Drug delivery system